That means the answer is not a simple yes or no
A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of Efinopegdutide in patients with non-alcoholic fatty liver disease
First synthesized in the 1990s, MT-2 is classified as a non-selective melanocortin receptor agonist, meaning it is structurally compatible with multiple receptor subtypes (MC1R, MC3R, MC4R, MC5R)
It is also known to boost energy levels, improve immune function, and support mental clarity and focus
Aflatoxin B1 (AFB1) is present in the environment as contaminant of cereal crops and groundnuts
Most of the time, this hair loss is temporary